Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability
- PMID: 15824318
- PMCID: PMC556294
- DOI: 10.1073/pnas.0500617102
Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability
Abstract
Several mutations in PTEN-induced putative kinase 1 (PINK1) gene have been reported to be associated with recessive parkinsonism. The encoded protein is predicted to be a Ser/Thr protein kinase targeted to mitochondria. In this study, we have investigated the effects of mutations on PINK1 kinase activity in vitro and on expression levels and localization in mammalian cells. We chose to examine two point mutations: G309D, which was originally reported to be stable and properly localized in cells and L347P, which is of interest because it is present at an appreciable carrier frequency in the Philippines. We were able to confirm kinase activity and produce artificial "kinase-dead" mutants that are stable but lack activity. The L347P mutation grossly destabilizes PINK1 and drastically reduces kinase activity, whereas G309D has much more modest effects on these parameters in vitro. This finding is in line with predictions based on homology modeling. We also examined the localization of PINK1 in transfected mammalian cells by using constructs that were tagged with myc or GFP at either end of the protein. These results show that PINK1 is processed at the N terminus in a manner consistent with mitochondrial import, but the mature protein also exists in the cytosol. The physiological relevance of this observation is not yet clear, but it implies that a portion of PINK1 may be exported after processing in the mitochondria.
Figures




Similar articles
-
Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism.Hum Mol Genet. 2005 Nov 15;14(22):3477-92. doi: 10.1093/hmg/ddi377. Epub 2005 Oct 5. Hum Mol Genet. 2005. PMID: 16207731
-
Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.Hum Mol Genet. 2008 Feb 15;17(4):602-16. doi: 10.1093/hmg/ddm334. Epub 2007 Nov 14. Hum Mol Genet. 2008. PMID: 18003639
-
PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.PLoS Biol. 2007 Jul;5(7):e172. doi: 10.1371/journal.pbio.0050172. Epub 2007 Jun 19. PLoS Biol. 2007. PMID: 17579517 Free PMC article.
-
N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.Curr Genet. 2020 Aug;66(4):693-701. doi: 10.1007/s00294-020-01062-2. Epub 2020 Mar 10. Curr Genet. 2020. PMID: 32157382 Review.
-
Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1).J Neurochem. 2008 Apr;105(1):18-33. doi: 10.1111/j.1471-4159.2008.05249.x. Epub 2008 Jan 23. J Neurochem. 2008. PMID: 18221368 Review.
Cited by
-
Biology of mitochondria in neurodegenerative diseases.Prog Mol Biol Transl Sci. 2012;107:355-415. doi: 10.1016/B978-0-12-385883-2.00005-9. Prog Mol Biol Transl Sci. 2012. PMID: 22482456 Free PMC article. Review.
-
PINK1-mediated phosphorylation of the Parkin ubiquitin-like domain primes mitochondrial translocation of Parkin and regulates mitophagy.Sci Rep. 2012;2:1002. doi: 10.1038/srep01002. Epub 2012 Dec 19. Sci Rep. 2012. PMID: 23256036 Free PMC article. Clinical Trial.
-
PINK1 import regulation; a fine system to convey mitochondrial stress to the cytosol.BMC Biol. 2018 Jan 10;16(1):2. doi: 10.1186/s12915-017-0470-7. BMC Biol. 2018. PMID: 29325568 Free PMC article. Review.
-
Protein degradation in Parkinson disease revisited: it's complex.J Clin Invest. 2009 Mar;119(3):442-5. doi: 10.1172/jci38619. J Clin Invest. 2009. PMID: 19306499 Free PMC article.
-
PINK1 and BECN1 relocalize at mitochondria-associated membranes during mitophagy and promote ER-mitochondria tethering and autophagosome formation.Autophagy. 2017 Apr 3;13(4):654-669. doi: 10.1080/15548627.2016.1277309. Epub 2017 Feb 17. Autophagy. 2017. PMID: 28368777 Free PMC article.
References
-
- Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. & Shimizu, N. (1998) Nature 392, 605–608. - PubMed
-
- Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) Science 299, 256–259. - PubMed
-
- Hilker, R., Klein, C., Ghaemi, M., Kis, B., Strotmann, T., Ozelius, L. J., Lenz, O., Vieregge, P., Herholz, K., Heiss, W. D. & Pramstaller, P. P. (2001) Ann. Neurol. 49, 367–376. - PubMed
-
- Broussolle, E., Lucking, C. B., Ginovart, N., Pollak, P., Remy, P. & Durr, A. (2000) Neurology 55, 877–879. - PubMed
-
- Scherfler, C., Khan, N. L., Pavese, N., Eunson, L., Graham, E., Lees, A. J., Quinn, N. P., Wood, N. W., Brooks, D. J. & Piccini, P. P. (2004) Brain 127, 1332–1342. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials